Prostate Cancer
Recent Abstracts
The treatment landscape of nonmetastatic castrate resistant prostate cancer: A contemporary perspective.
April 2, 2024
Advances in Radioligand Theranostics in Oncology.
April 2, 2024
Testosterone recovery after androgen deprivation therapy in localised prostate cancer: Long-term data from two randomised trials.
April 2, 2024
Toward Informed Selection and Interpretation of Clinical Genomic Tests in Prostate Cancer.
April 1, 2024
Magnetic Resonance Imaging, Clinical, and Biopsy Findings in Suspected Prostate Cancer: A Systematic Review and Meta-Analysis.
April 1, 2024
The association of patient and disease characteristics with the overtreatment of low-risk prostate cancer from 2010 to 2016.
April 1, 2024
Randomized Phase II Study Evaluating the Addition of Pembrolizumab to Radium-223 in Metastatic Castration-resistant Prostate Cancer.
April 1, 2024
Tumor upgrading among very favorable intermediate-risk prostate cancer patients treated with robot-assisted radical prostatectomy: how can it impact the clinical course?
April 1, 2024
Military service and health-related quality of life among gay and bisexual prostate cancer survivors: Results from the Restore -2 study.
March 31, 2024
Quantification and molecular correlates of tertiary lymphoid structures in primary prostate cancer.
March 29, 2024
The Current Therapeutic Landscape for Metastatic Prostate Cancer.
March 29, 2024
Exploring Information Seeking Anxiety Among Localized Prostate Cancer Patients.
March 29, 2024
Clinical validation of circulating GDF15/MIC-1 as a marker of response to docetaxel and survival in men with metastatic castration-resistant prostate cancer.
March 29, 2024
Racial differences in postpandemic trends in prostate-specific antigen screening.
March 29, 2024
Discovery of CBPD-409 as a Highly Potent, Selective, and Orally Efficacious CBP/p300 PROTAC Degrader for the Treatment of Advanced Prostate Cancer.
March 28, 2024
A practical guide for assessing and managing cardiovascular risk during androgen-deprivation therapy in patients with prostate cancer.
March 28, 2024
Interaction of patient age and high-grade prostate cancer on targeted biopsies of MRI suspicious lesions.
March 28, 2024
Patterns of B-cell lymphocyte expression changes in pre- and post-malignant prostate tissue are associated with prostate cancer progression.
March 28, 2024
Real-world prostate-specific antigen reduction and survival outcomes of metastatic hormone-sensitive prostate cancer patients treated with apalutamide: An observational, retrospective, and multicentre study.
March 28, 2024
Clinically-observed FOXA1 mutations upregulate SEMA3C through transcriptional derepression in prostate cancer.
March 27, 2024
Page 29 of 1407
Start
Prev
24
25
26
27
28
29
30
31
32
33
Next
End
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free